Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWS Health Care Typ O

+ Add to Watchlist

DWSPHAK:GR

239.86 EUR 1.98 0.83%

As of 01:59:30 ET on 03/30/2015.

Snapshot for DWS Health Care Typ O (DWSPHAK)

Year To Date: +19.77% 3-Month: +19.86% 3-Year: +33.29% 52-Week Range: 144.76 - 246.25
1-Month: +4.39% 1-Year: +56.48% 5-Year: +21.99% Beta vs MSGUHC: 0.97

Mutual Fund Chart for DWSPHAK

No chart data available.
  • DWSPHAK:GR 237.88
  • 1M
  • 1Y
Interactive DWSPHAK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWSPHAK

DWS Health Care Typ O is an open-end investment fund incorporated in Germany and Austria. The Fund's objective is income and growth. DWS Health Care Typ O invests in global pharmaceutical stocks with emphasis on large, multinational pharmaceutical companies, as well as innovative biotechnology stocks.

Inception Date: 11-10-1997 Telephone: Tel. 49-1803-10111011
Managers: THOMAS E BUCHER / HOLGER GEISSLER
Web Site: www.dws.de

Fundamentals for DWSPHAK

NAV (on 2015-03-27) 237.88
Assets (M) (on 2015-03-27) 390.69
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment -

Dividends for DWSPHAK

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for DWSPHAK

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.70
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.71

Top Fund Holdings for DWSPHAK

Filing Date: 12/30/2014
Name Position Value % of Total
Novartis AG 207,000 15,941,975 5.385%
Express Scripts Holding Co 177,076 12,502,734 4.223%
Gilead Sciences Inc 150,300 12,012,148 4.058%
Pfizer Inc 442,300 11,403,998 3.852%
Covidien PLC 123,750 10,527,568 3.556%
Johnson & Johnson 110,010 9,517,724 3.215%
Bayer AG 78,050 8,913,310 3.011%
Celgene Corp 88,650 8,335,263 2.816%
Amgen Inc 61,150 8,179,619 2.763%
AbbVie Inc 146,900 8,101,249 2.737%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil